scholarly journals Racial differences in human papilloma virus types amongst United States women with HIV and cervical precancer

AIDS ◽  
2018 ◽  
Vol 32 (18) ◽  
pp. 2821-2826 ◽  
Author(s):  
Marla J. Keller ◽  
Robert D. Burk ◽  
L. Stewart Massad ◽  
Isam-Eldin Eltoum ◽  
Nancy A. Hessol ◽  
...  
Keyword(s):  
United States ◽  
Human Papilloma Virus ◽  
Racial Differences ◽  
Papilloma Virus ◽  
Cervical Precancer ◽  
Women With Hiv

scholarly journals 1641. A Comparison of Human Papilloma Virus Infection Prevalence Trends Pre- and Post-HPV Vaccine Implementation

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S599-S599
Author(s):  
Patrick Ovie. Fueta ◽  
Onyema Greg Chido-Amajuoyi
Keyword(s):  
United States ◽  
Human Papilloma Virus ◽  
Hpv Vaccine ◽  
Human Papilloma Virus Infection ◽  
The United States ◽  
Hpv Infection ◽  
Infection Prevalence ◽  
Transmitted Infection ◽  
Papilloma Virus ◽  
The Impact

Abstract Background Human papilloma virus (HPV) is the most common sexually transmitted infection in the United States, with an annual incidence rate of approximately 14 million people. The HPV vaccine has been demonstrated to be highly effective in the prevention of HPV infection and HPV-associated diseases. This study aims to evaluate the impact of HPV vaccine on the prevalence of HPV infection in the United States and evaluate the trends of disease prevalence pre- and post-HPV vaccine implementation. Methods We conducted a secondary data analysis of the National Health and Education Survey (NHANES) for trends in HPV infection from 2003 to 2016. The analysis was grouped into a pre-HPV vaccine implementation (2003–2006) cohort including 4064 females, aged 18–59 years; and a post-HPV vaccine implementation (2007–2016) cohort which included 10718 females, aged 18–59 years. Further analysis of HPV infection prevalence, pre- and post-HPV vaccine implementation, stratified by sociodemographic characteristics were conducted. Results The prevalence of HPV infection prior to HPV vaccine implementation was 43.98% (95 CI 42.71%–46.58%) compared with 40.55% (95 C.I 40.55%–40.56%) in the post-HPV vaccine implementation era. Among females with HPV infections in the post-HPV vaccine implementation cohort 82.6 (95% CI 80.41%–83.42%) were unvaccinated. In both cohorts, black females had a significantly higher prevalence of HPV with a prevalence rate of 18.56% (95% CI 18.23%–20.56%) in the pre-HPV vaccine implementation cohort, and 15.61% (95% CI 14.82 – 19.4%) in the post-HPV vaccine implementation cohort. Females with less than high school education had a higher prevalence of HPV in the pre and post- HPV vaccine implementation cohorts with prevalence rates of 25.77% (95% CI 23.44%–28.72%) and 24.96% (95% CI 23.41%–25.67%), respectively. Conclusion The results suggest that HPV infection prevalence has declined since the implementation of HPV vaccine to US national immunization program. Our findings highlight disparities in HPV infection prevalence by race and educational status, and these patterns are in keeping with HPV-associated disease such as warts and HPV-associated cancers. Disclosures All authors: No reported disclosures.

scholarly journals New United States guidelines recommending human papilloma virus screening for women with borderline cervical cytological abnormalities

2002 ◽  
Vol 6 (22) ◽  
Author(s):  
◽  
Keyword(s):  
United States ◽  
Cervical Cancer ◽  
American Medical Association ◽  
Human Papilloma Virus ◽  
The United States ◽  
Hpv Testing ◽  
Papilloma Virus ◽  
Consensus Statements ◽  
Cytological Abnormalities ◽  
Virus Screening

Following two conferences which took place in the United States (US) last year, the American Medical Association has recently published two consensus statements concerning screening for and management of cervical cancer (1-3). It is recommended that human papilloma virus (HPV) testing become an integral part of both screening and clinical management of cervical cytological abnormalities.

Sexually Transmitted Diseases

2014 ◽  
pp. 46-57
Author(s):  
Sigal Yawetz ◽  
Jennifer A. Johnson
Keyword(s):  
United States ◽  
Herpes Simplex ◽  
Human Papilloma Virus ◽  
Sexually Transmitted Diseases ◽  
Genital Tract ◽  
The United States ◽  
Secondary Syphilis ◽  
Surveillance Data ◽  
Papilloma Virus ◽  
Sexually Transmitted

Awide variety of infectious agents are sexually transmitted (see table 6.1), causing an array of disease manifestations that are frequently not confined to the genital tract. According to the most recent Centers for Disease Control (CDC) surveillance data from 2009, the most common reportable sexually transmitted diseases (STDs) in the United States are chlamydia, gonorrhea, and primary and secondary syphilis, respectively, and the annual incidence of chlamydia and early syphilis is still increasing. Case reporting for more common STDs, such as genital herpes simplex virus (HSV), trichomonas, and human papilloma virus (HPV) infections is not required. In this chapter several of the most common ulcerative and nonulcerative STDs are discussed. The viral hepatitides (A, B, and C) and HIV merit individual attention and are not addressed in this chapter. Vaginitis and HPV are also not discussed here.

scholarly journals Preventing Human Papilloma Virus through Community Education and Vaccination

2021 ◽  
Author(s):  
Celeste Mulry Baldwin ◽  
Lisa Rinke
Keyword(s):  
United States ◽  
Public Schools ◽  
Human Papilloma Virus ◽  
Transmitted Disease ◽  
Healthcare Providers ◽  
Main Tool ◽  
The United States ◽  
Papilloma Virus ◽  
Sexually Transmitted ◽  
Parents And Children

Human Papilloma Virus (HPV) affects many members of the community. To better educate the community in a participatory manner, engaging those outside of the health care arena is necessary. To prevent the spread of the disease in the United States, reaching the parents of children at the vulnerable age of 9–11 years of age is critical. The barriers to education of parents and children around the spread of a sexually transmitted disease are vast and difficult to overcome. However, the use of proven vaccinations give healthcare providers and community advocates the main tool for prevention of the spread of the disease. It is often taboo to discuss anything related to sexual promiscuity or sexual activity in the United States in the public schools. The biggest myth includes the fear parents and grandparents have is that if HPV is talked about, then the child may become sexually active sooner. This myth needs to be challenged with science and reality including taking on the those vehemently opposed to vaccines, known as “Anti-Vaxers” that obstruct vaccine education. The strategies utilized in public health outreach to the community should be reviewed and uniquely developed for each diverse community to overcome the challenges in the prevention of HPV.

scholarly journals Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study

2013 ◽  
Vol 22 (10) ◽  
pp. 1762-1770 ◽  
Author(s):  
Matthew B. Schabath ◽  
Luisa L. Villa ◽  
Hui-Yi Lin ◽  
William J. Fulp ◽  
Gabriel O. Akogbe ◽  
...  
Keyword(s):  
Human Papilloma Virus ◽  
Racial Differences ◽  
Papilloma Virus ◽  
Hpv In Men
Sign in / Sign up

Export Citation Format

Share Document